Value proposition

Federal Institute for Vaccines and Biomedicines in Germany.

The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, in Langen near Frankfurt/Main is a senior federal authority reporting to the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). It is responsible for the research, assessment, and marketing authorisation of biomedicines for human use and immunological veterinary medicinal products. Its remit also includes the authorisation of clinical trials and pharmacovigilance, i.e. recording and evaluation of potential adverse effects.

Other duties of the institute include official batch control, scientific advice and inspections. In-house experimental research in the field of biomedicines and life science form an indispensable basis for the manifold tasks performed at the institute.

The Paul-Ehrlich-Institut, with its more than 800 members of staff, also has advisory functions nationally (federal government, federal states (Länder)), and internationally (World Health Organisation, European Medicines Agency, European Commission, Council of Europe etc.).

www.pei.de/impress

Biomedicine, Vaccines, Pharmacovigilance, Research, Immunology, Allergology, Advanced therapy medicinal products, Gene therapeutics, Cell therapeutics, Tissue engineered products, Blood products, Stem cell preparations, Tissue preparations, Immunological veterinary medicines, Life Sciences, Therapeutic and diagnostic allergens, Medicine safety, Regulatory science, Public health, and Global health